![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_57ea1cb9bced723b6ee77d5f46571b58.svg) | 2-[[26,27,28-Tris(carboxymethoxy)-2,8,14,20-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaen-25-yl]oxy]acetic acid | IC50 | 0.65 [1], 0.71 [2], 12.59 [3], 15.0 [4] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_be4729899876fbb52af1bd0dc2d0f7fc.svg) | 4-Tert-Butylcalix[4]arene tetraacetic acid | IC50 | 3.7 [1], 4.3 [2], 25.12 [3], 150.0 [4] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_489bb9b3c83c028f87b12560a7921185.svg) | 2-[[17,25,27-Tris(carboxymethoxy)-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaenyl]oxy]acetic acid | IC50 | 14.0 [1], 21.0 [2], 50.12 [3], 1300.0 [4] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_da615617cd9372f18ee4de3c52b6e5d9.svg) | 2-Acetamido-2-deoxy-beta-D-glucopyranose | IC50 | 125892.54 [1], 316227.77 [2], 1000000.0 [3] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_e1241e5e727df40a03fb5f0cb4f9c909.svg) | Duvoglustat hydrochloride | IC50 | 630957.34 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_32f8e553f62a879c8b0c85fd4f4fb5b5.svg) | 2-(Acetylamino)-2-deoxy-alpha-D-mannopyranose | IC50 | 1000000000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_285db470dcdb2f337becc0a67037d911.svg) | N-[(2R,3R,4R,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-[[11,17,23-tris[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]carbamothioylamino]-25,26,27,28-tetrapropoxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]carbamothioylamino]oxan-3-yl]acetamide | IC50 | 0.5 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_9fec4099f2d95d597756909e2b605956.svg) | 2-[[5,11,17,23-Tetratert-butyl-26,27,28-tris(carboxymethoxy)-2,8,14,20-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaen-25-yl]oxy]acetic acid | IC50 | 398107.17 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_505c74dbddad14531b1c5a91ca2e362f.svg) | 4-[[11,17,23-Tris[(4-carboxyphenyl)diazenyl]-25,26,27,28-tetrahydroxy-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]diazenyl]benzoic acid | IC50 | 63.1 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_d3133e3f6a742d0d7b9ef48b9733dae2.svg) | 2-[[11,23,26,28-Tetratert-butyl-17,25,27-tris(carboxymethoxy)-5-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaenyl]oxy]acetic acid | IC50 | 251188.64 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_9aa6fd640c18479cd99e96f2f5a59a65.svg) | 2-[[5,11,17,23-Tetratert-butyl-27-(carboxymethoxy)-26,28-dihydroxy-2,8,14,20-tetraoxo-2lambda4,8lambda4,14lambda4,20lambda4-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(24),3,5,7(28),9,11,13(27),15(26),16,18,21(25),22-dodecaen-25-yl]oxy]acetic acid | IC50 | 79432.82 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_db60bddddea849ad8f2a692be127aa90.svg) | 2-[[27-(Carboxymethoxy)-26,28-dihydroxy-2,8,14,20-tetrathiapentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaen-25-yl]oxy]acetic acid | IC50 | 79.43 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_eba562c3872a84ebee00de55499d2ef6.svg) | 2-[[26,27,28-Tris(carboxymethoxy)-25-pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3(28),4,6,9(27),10,12,15,17,19(26),21,23-dodecaenyl]oxy]acetic acid | IC50 | 31622.78 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_1fddeee420d75d2d4d65ee69fe2cb3fd.svg) | [(2R,3R,4S,5S,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-(triazol-1-yl)oxan-3-yl] acetate | IC50 | 3981.07 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_916955c00c34cad350a33957ced5939f.svg) | N-[(2R,3S,4R,5R,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | IC50 | 1000000000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_47caf142713caf7aed0b254d99276920.svg) | N-[(2R,3S,4R,5R,6R)-2-[(2R,3R,4R,5S)-4,5-Dihydroxy-2-(hydroxymethyl)piperidin-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | IC50 | 501187.23 [1] |
![](https://images.aatbio.com/dataset/ic50/early-activation-antigen-cd69_06e432f11c50e32f5f0438e15d76662a.svg) | N-[(2R,3S,4R,5S,6R)-2-[(2R,3R,4R,5S)-4,5-Dihydroxy-2-(hydroxymethyl)piperidin-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide | IC50 | 31622.78 [1] |